STC Reports Today as a 33% Gap Between Price and Consensus Tests the Market

STC reports Q3 results this morning, October 22, with the stock at $52.57 after recovering fractionally yesterday but still down 17% over the past month. The central tension remains unchanged from yesterday's note: the Street's mean price target is $76.25, a gap of roughly 33% that reflects either a genuine mispricing or an analyst community that has not yet fully revised to match what the market is already pricing.

The positioning picture is consistent with the article published yesterday. Options remain tilted toward calls rather than puts: the put/call ratio is 0.47, well below its 20-day average of 1.07. That is a notable contrast to late September, when the ratio briefly hit 3.0 during heavy hedging activity. That defensive positioning has fully unwound. The borrow market continues to show no short-side conviction. Short interest has fallen 17% over the past month to 3.76% of the float, and availability is extraordinarily loose at around 3,959%, meaning the lending pool is barely touched. Borrowing costs remain negligible at 0.47% annualised. None of this points to a crowded short trade.

The analyst debate centres on whether margin compression is temporary or structural. Bulls point to a projected doubling of segment earnings between 2025 and 2027, rising commercial revenues, and a fee-per-file trajectory that suggests improving unit economics. Bears flag that operating margin estimates have been cut, the commercial growth rate that ran at 46% year over year in Q2 is expected to slow materially in the back half, and purchase market conditions remain uncertain. Citizens trimmed its target to $75 from $80 on October 12 while keeping its outperform rating, a pattern consistent with a Street that still believes in the thesis but is pulling back near-term numbers. Peers FAF and FNF both gained more than 3% on the week, making STC's relative weakness more visible.

The print this morning is less a test of whether commercial real estate activity is healthy and more a test of whether Stewart can demonstrate that its margin trajectory is turning, rather than still declining.